Imaging can guide whether liquid biopsy will benefit individual glioblastoma patients
New research from the Perelman School of Medicine and the Abramson Cancer Center shows brain imaging may be able to predict when a blood test known as a liquid biopsy would or would not produce clinically actionable information.
FULL STORY AT Penn Medicine News →